This past week five IPOs debuted, three updated terms and eight new deals filed.
Many of the deals this past week were priced by the buy-side and subsequently came below their prevailing ranges. However, this was not the case for the EQT GP Holdings (NYSE: EQGP) deal which priced $3.00 above the $21.00-$24.00 range. The deal opened for trading at $32.00—good for a 19% pop. Fortress Transportation and Infrastructure Investors (NYSE: FTAI) priced $2.00 below range ($17.00) and opened $1.00 lower with a trade of $16.00. Fenix Parts (Nasdaq: FENX) priced $1.00 below range and opened flat. ‘FENX’ traded well in the after market and hit a high of $9.25 before closing the week at $9.00–good for a 13% boost above the offering price. Arcadia Biosciences (Nasdaq: RKDA) re-worked its terms and priced $5.00 below the initial $13-$15 range and upsized its offering. The deal opened at $7.49 and never traded above the $8.00 IPO price on day one.
It should be noted that three deals that were holdovers from last week, (Anterios (Nasdaq: ANTE), Gelesis (Nasdaq: GLSS) and Multivir (Nasdaq: MVIR) have all been postponed… due to what the underwriter claimed as “market conditions”.
Looking ahead to this week there are five deals on the schedule with….
(SUBSCRIPTION NEEDED)
Please check your emails early and often. We may upgrade or downgrade an IPO and or secondary –sometimes with not as much notice as we would like to give. If you have interest in IPOs do NOT delay your IOI’s (hopefully they are already in)…you can always cancel them. We will keep you posted if and as when…we have anything pertinent to add. The current number of “active” IPOs in the pipeline as of 5/15/15 is 128. Good luck trading!